360 related articles for article (PubMed ID: 10874895)
1. [Prevention of thrombosis with subcutaneous recombinant hirudin in heparin-induced thrombocytopenia type II. A pilot study].
Huhle G; Hoffmann U; Hoffmann I; Harenberg J; Heene DL
Dtsch Med Wochenschr; 2000 Jun; 125(22):686-91. PubMed ID: 10874895
[TBL] [Abstract][Full Text] [Related]
2. A new therapeutic option by subcutaneous recombinant hirudin in patients with heparin-induced thrombocytopenia type II: a pilot study.
Huhle G; Hoffmann U; Hoffmann I; Liebe V; Harenberg JF; Heene DL
Thromb Res; 2000 Aug; 99(4):325-34. PubMed ID: 10963783
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patient.
Nowak G; Bucha E; Brauns I; Czerwinski R
Wien Klin Wochenschr; 1997 May; 109(10):354-8. PubMed ID: 9200807
[TBL] [Abstract][Full Text] [Related]
4. [Prevention of thromboembolism as a cause of thromboembolic complications. A study of the incidence of heparin-induced thrombocytopenia type II].
Ganzer D; Gutezeit A; Mayer G; Greinacher A; Eichler P
Z Orthop Ihre Grenzgeb; 1997; 135(6):543-9. PubMed ID: 9499523
[TBL] [Abstract][Full Text] [Related]
5. Recombinant hirudin as an alternative for anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: a 1-year experience in 57 patients.
Koster A; Hansen R; Kuppe H; Hetzer R; Crystal GJ; Mertzlufft F
J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):243-8. PubMed ID: 10890473
[TBL] [Abstract][Full Text] [Related]
6. A pilot study of subcutaneous recombinant hirudin (HBW 023) in the treatment of deep vein thrombosis.
Schiele F; Vuillemenot A; Kramarz P; Kieffer Y; Soria J; Soria C; Camez A; Mirshahi MC; Bassand JP
Thromb Haemost; 1994 May; 71(5):558-62. PubMed ID: 8091380
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulant efficacy of PEG-Hirudin in patients on maintenance hemodialysis.
Pöschel KA; Bucha E; Esslinger HU; Ulbricht K; Nörtersheuser P; Stein G; Nowak G
Kidney Int; 2004 Feb; 65(2):666-74. PubMed ID: 14717940
[TBL] [Abstract][Full Text] [Related]
8. [Heparin-induced thrombocytopenia after elective hip joint replacement with postoperative prevention of thromboembolism with low-molecular-weight heparin].
Marx A; Huhle G; Hoffmann U; Wang LC; Schüle B; Jani L; Harenberg J
Z Orthop Ihre Grenzgeb; 1999; 137(6):536-9. PubMed ID: 10666863
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamic and safety results of PEG-Hirudin in healthy volunteers.
Esslinger HU; Haas S; Maurer R; Lassmann A; Dübbers K; Müller-Peltzer H
Thromb Haemost; 1997 May; 77(5):911-9. PubMed ID: 9184402
[TBL] [Abstract][Full Text] [Related]
10. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study.
Greinacher A; Völpel H; Janssens U; Hach-Wunderle V; Kemkes-Matthes B; Eichler P; Mueller-Velten HG; Pötzsch B
Circulation; 1999 Jan 5-12; 99(1):73-80. PubMed ID: 9884382
[TBL] [Abstract][Full Text] [Related]
11. Direct thrombin inhibition with Rec-hirudin CGP 39393 as prophylaxis of thromboembolic complications after total hip replacement.
Eriksson BI; Kälebo P; Ekman S; Lindbratt S; Kerry R; Close P
Thromb Haemost; 1994 Aug; 72(2):227-31. PubMed ID: 7831657
[TBL] [Abstract][Full Text] [Related]
12. Management of heparin-associated thrombocytopenia in pregnancy with subcutaneous r-hirudin.
Huhle G; Geberth M; Hoffmann U; Heene DL; Harenberg J
Gynecol Obstet Invest; 2000; 49(1):67-9. PubMed ID: 10629377
[TBL] [Abstract][Full Text] [Related]
13. Hirudin-based anticoagulant strategy during isolated limb perfusion in a patient with heparin-induced thrombocytopenia.
Lindemann W; Richter S; Schilling MK
Melanoma Res; 2005 Aug; 15(4):287-90. PubMed ID: 16034307
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular drug highlight: hirudin.
Cheng-Lai A
Heart Dis; 1999; 1(1):41-9. PubMed ID: 11720603
[TBL] [Abstract][Full Text] [Related]
15. Treatment of an acute flush reaction caused by subcutaneous r-hirudin with pegylated hirudin.
Harenberg J; Hoffmann U; Huhle G; Song XH; Wang LC
Br J Haematol; 2000 Mar; 108(3):528-30. PubMed ID: 10759710
[TBL] [Abstract][Full Text] [Related]
16. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
[TBL] [Abstract][Full Text] [Related]
17. Monitoring of r-hirudin anticoagulation during cardiopulmonary bypass--assessment of the whole blood ecarin clotting time.
Pötzsch B; Madlener K; Seelig C; Riess CF; Greinacher A; Müller-Berghaus G
Thromb Haemost; 1997 May; 77(5):920-5. PubMed ID: 9184403
[TBL] [Abstract][Full Text] [Related]
18. [Heparin induced thrombocytopenia type II after the use of low-molecular weight heparin. Case report and review of the literature].
Franke J; Schaeper O; Kayser R; Mahlfeld K
Unfallchirurg; 2003 Jan; 106(1):77-81. PubMed ID: 12552397
[TBL] [Abstract][Full Text] [Related]
19. [Heparin-induced thrombocytopenia. Diagnosis, clinical course and therapeutic alternatives].
Scheffold N; Maitra R; Cyran J
Schweiz Med Wochenschr; 1998 Apr; 128(16):609-15. PubMed ID: 9611303
[TBL] [Abstract][Full Text] [Related]
20. Heparin-induced thrombocytopenia in pediatrics.
Severin T; Sutor AH
Semin Thromb Hemost; 2001 Jun; 27(3):293-9. PubMed ID: 11446663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]